Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects
Obstructive airway diseases, e.g., chronic obstructive pulmonary disease (COPD) and asthma, represent leading causes of morbidity and mortality worldwide. However, the efficacy of currently available inhaled therapeutics is not sufficient for arresting disease progression and decreasing mortality, h...
Saved in:
Main Authors: | You Xu (Author), Aneesh Thakur (Author), Yibang Zhang (Author), Camilla Foged (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
by: Abishek Wadhwa, et al.
Published: (2020) -
Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022) -
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations
by: Danforth P. Miller, et al.
Published: (2021) -
The future of inhalation therapy in chronic obstructive pulmonary disease
by: Mario Cazzola, et al.
Published: (2022) -
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
by: Dalia T. Abdeldaim, et al.
Published: (2023)